Hemodynamic Analysis of Cerebral AVMs with 3D Phase-Contrast MR Imaging

References

1. 1.↵
   1. Gross BA,
   2. Du R

   . Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 2013;118:437–43 doi:10.3171/2012.10.JNS121280 pmid:23198804

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kim H,
   2. Al-Shahi Salman R,
   3. McCulloch CE, et al

   ; MARS Coinvestigators. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology 2014;83:590–97 doi:10.1212/WNL.0000000000000688 pmid:25015366

   CrossRefPubMed
3. 3.↵
   1. Fennell VS,
   2. Martirosyan NL,
   3. Atwal GS, et al

   . Hemodynamics associated with intracerebral arteriovenous malformations: the effects of treatment modalities. Neurosurgery 2018;83:611–21 doi:10.1093/neuros/nyx560 pmid:29267943

   CrossRefPubMed
4. 4.↵
   1. Spetzler RF,
   2. Hargraves RW,
   3. McCormick PW, et al

   . Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:918–23 doi:10.3171/jns.1992.76.6.0918 pmid:1588424

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Kader A,
   2. Young WL,
   3. Pile-Spellman J, et al

   . The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1994;34:807–08; discussion 807–08 doi:10.1227/00006123-199405000-00003 pmid:7914356

   CrossRefPubMed
6. 6.↵
   1. Miyasaka Y,
   2. Kurata A,
   3. Irikura K, et al

   . The influence of vascular pressure and angiographic characteristics on haemorrhage from arteriovenous malformations. Acta Neurochir (Wien) 2000;142:39–43 doi:10.1007/s007010050005 pmid:10664374

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Mast H,
   2. Mohr JP,
   3. Thompson JL, et al

   . Transcranial Doppler ultrasonography in cerebral arteriovenous malformations: diagnostic sensitivity and association of flow velocity with spontaneous hemorrhage and focal neurological deficit. Stroke 1995;26:1024–27 doi:10.1161/01.str.26.6.1024 pmid:7762018

   Abstract/FREE Full Text
8. 8.↵
   1. Norris JS,
   2. Valiante TA,
   3. Wallace MC, et al

   . A simple relationship between radiological arteriovenous malformation hemodynamics and clinical presentation: a prospective, blinded analysis of 31 cases. J Neurosurg 1999;90:673–79 doi:10.3171/jns.1999.90.4.0673 pmid:10193612

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Todaka T,
   2. Hamada J,
   3. Kai Y, et al

   . Analysis of mean transit time of contrast medium in ruptured and unruptured arteriovenous malformations: a digital subtraction angiographic study. Stroke 2003;34:2410–14 doi:10.1161/01.STR.0000089924.43363.E3 pmid:12970520

   Abstract/FREE Full Text
10. 10.↵
    1. Chen X,
    2. Cooke DL,
    3. Saloner D, et al

    . Higher flow is present in unruptured arteriovenous malformations with silent intralesional microhemorrhages. Stroke 2017;48:2881–84 doi:10.1161/STROKEAHA.117.017785 pmid:28855391

    Abstract/FREE Full Text
11. 11.↵
    1. Burkhardt JK,
    2. Chen X,
    3. Winkler EA, et al

    . Delayed venous drainage in ruptured arteriovenous malformations based on quantitative color-coded digital subtraction angiography. World Neurosurg 2017;104:619–27 doi:10.1016/j.wneu.2017.04.120 pmid:28457930

    CrossRefPubMed
12. 12.↵
    1. Ansari SA,
    2. Schnell S,
    3. Carroll T, et al

    . Intracranial 4D-flow MRI: toward individualized assessment of arteriovenous malformation hemodynamics and treatment-induced changes. AJNR Am J Neuroradiol 2013;34:1922–28 doi:10.3174/ajnr.A3537 pmid:23639564

    Abstract/FREE Full Text
13. 13.↵
    1. Raoult H,
    2. Bannier E,
    3. Maurel P, et al

    . Hemodynamic quantification in brain arteriovenous malformations with time-resolved spin-labeled magnetic resonance angiography. Stroke 2014;45:2461–64 doi:10.1161/STROKEAHA.114.006080 pmid:24984747

    Abstract/FREE Full Text
14. 14.↵
    1. Alaraj A,
    2. Amin-Hanjani S,
    3. Shakur SF, et al

    . Quantitative assessment of changes in cerebral arteriovenous malformation hemodynamics after embolization. Stroke 2015;46:942–47 doi:10.1161/STROKEAHA.114.008569 pmid:25744522

    Abstract/FREE Full Text
15. 15.↵
    1. Wu C,
    2. Ansari SA,
    3. Honarmand AR, et al

    . Evaluation of 4D vascular flow and tissue perfusion in cerebral arteriovenous malformations: influence of Spetzler-Martin grade, clinical presentation, and AVM risk factors. AJNR Am J Neuroradiol 2015;36:1142–49 doi:10.3174/ajnr.A4259 pmid:25721076

    Abstract/FREE Full Text
16. 16.↵
    1. Shakur SF,
    2. Liesse K,
    3. Amin-Hanjani S, et al

    . Relationship of cerebral arteriovenous malformation hemodynamics to clinical presentation, angioarchitectural features, and hemorrhage. Neurosurgery 2016;63(Suppl 1):136–40 doi:10.1227/NEU.0000000000001285 pmid:27399378

    CrossRefPubMed
17. 17.↵
    1. Brunozzi D,
    2. Hussein AE,
    3. Shakur SF, et al

    . Contrast time-density time on digital subtraction angiography correlates with cerebral arteriovenous malformation flow measured by quantitative magnetic resonance angiography, angioarchitecture, and hemorrhage. Neurosurgery 2018;83:210–16 doi:10.1093/neuros/nyx351 pmid:29106647

    CrossRefPubMed
18. 18.↵
    1. Conway SA,
    2. Bowling SM,
    3. Geyer JD, et al

    . Quantitative magnetic resonance angiography of the cerebrovasculature in physiologic and pathologic states. J Neuroimaging 2008;18:34–37 doi:10.1111/j.1552-6569.2007.00171.x pmid:18190493

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Aristova M,
    2. Vali A,
    3. Ansari SA, et al

    . Standardized evaluation of cerebral arteriovenous malformations using flow distribution network graphs and dual-VENC 4D-flow MRI. J Magn Reson Imaging 2019;50:1718–30 doi:10.1002/jmri.26784 pmid:31070849

    CrossRefPubMed
20. 20.↵
    1. Orita E,
    2. Murai Y,
    3. Sekine T, et al

    . Four-dimensional flow MRI analysis of cerebral blood flow before and after high-flow extracranial-intracranial bypass surgery with internal carotid artery ligation. Neurosurgery 2019;85:58–64 doi:10.1093/neuros/nyy192 pmid:29757425

    CrossRefPubMed
21. 21.↵
    1. Wu C,
    2. Schnell S,
    3. Vakil P, et al

    . In vivo assessment of the impact of regional intracranial atherosclerotic lesions on brain arterial 3D hemodynamics. AJNR Am J Neuroradiol 2017;38:515–22 doi:10.3174/ajnr.A5051 pmid:28057635

    Abstract/FREE Full Text
22. 22.↵
    1. Spetzler RF,
    2. Martin NA

    . A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83 doi:10.3171/jns.1986.65.4.0476 pmid:3760956

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Lotz J,
    2. Meier C,
    3. Leppert A, et al

    . Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics 2002;22:651–71 doi:10.1148/radiographics.22.3.g02ma11651 pmid:12006694

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Illies T,
    2. Forkert ND,
    3. Saering D, et al

    . Persistent hemodynamic changes in ruptured brain arteriovenous malformations. Stroke 2012;43:2910–15 doi:10.1161/STROKEAHA.112.669945 pmid:23091120

    Abstract/FREE Full Text
25. 25.↵
    1. Kubalek R,
    2. Moghtaderi A,
    3. Klisch J, et al

    . Cerebral arteriovenous malformations: influence of angioarchitecture on bleeding risk. Acta Neurochir (Wien) 2003;145:1045–52; discussion 1052 doi:10.1007/s00701-003-0143-x pmid:14663561

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Lin TM,
    2. Yang HC,
    3. Lee CC, et al

    . Stasis index from hemodynamic analysis using quantitative DSA correlates with hemorrhage of supratentorial arteriovenous malformation: a cross-sectional study. J Neurosurg 2020;132:1574–82 doi:10.3171/2019.1.JNS183386 pmid:31026828

    CrossRefPubMed
27. 27.↵
    1. Rijnberg FM,
    2. van Assen HC,
    3. Juffermans JF, et al

    . Reduced scan time and superior image quality with 3D flow MRI compared to 4D-flow MRI for hemodynamic evaluation of the Fontan pathway. Sci Rep 2021;11:6507 doi:10.1038/s41598-021-85936-6 pmid:33753790

    CrossRefPubMed
28. 28.↵
    1. Schnell S,
    2. Ansari SA,
    3. Wu C, et al

    . Accelerated dual-VENC 4D-flow MRI for neurovascular applications. J Magn Reson Imaging 2017;46:102–14 doi:10.1002/jmri.25595 pmid:28152256

    CrossRefPubMed
29. 29.↵
    1. Bammer R,
    2. Hope TA,
    3. Aksoy M, et al

    . Time-resolved 3D quantitative flow MRI of the major intracranial vessels: initial experience and comparative evaluation at 1.5T and 3.0T in combination with parallel imaging. Magn Reson Med 2007;57:127–40 doi:10.1002/mrm.21109 pmid:17195166

    CrossRefPubMed
30. 30.↵
    1. Rivera-Rivera LA,
    2. Turski P,
    3. Johnson KM, et al

    . 4D-flow MRI for intracranial hemodynamics assessment in Alzheimer’s disease. J Cereb Blood Flow Metab 2016;36:1718–30 doi:10.1177/0271678X15617171 pmid:26661239

    CrossRefPubMed
31. 31.↵
    1. Nett EJ,
    2. Johnson KM,
    3. Frydrychowicz A, et al

    . Four-dimensional phase contrast MRI with accelerated dual velocity encoding. J Magn Reson Imaging 2012;35:1462–71 doi:10.1002/jmri.23588 pmid:22282344

    CrossRefPubMed
32. 32.↵
    1. Sato S,
    2. Kodama N,
    3. Sasaki T, et al

    . Perinidal dilated capillary networks in cerebral arteriovenous malformations. Neurosurgery 2004;54:163–70 doi:10.1227/01.neu.0000097518.57741.be pmid:14683554

    CrossRefPubMed
33. 33.↵
    1. Zarrinkoob L,
    2. Ambarki K,
    3. Wåhlin A, et al

    . Blood flow distribution in cerebral arteries. J Cereb Blood Flow Metab 2015;35:648–54 doi:10.1038/jcbfm.2014.241 pmid:25564234

    CrossRefPubMed
34. 34.↵
    1. Amin-Hanjani S,
    2. Du X,
    3. Pandey DK, et al

    . Effect of age and vascular anatomy on blood flow in major cerebral vessels. J Cereb Blood Flow Metab 2015;35:312–18 doi:10.1038/jcbfm.2014.203 pmid:25388677

    CrossRefPubMed
35. 35.↵
    1. Althouse AD

    . Adjust for multiple comparisons? It’s not that simple. Ann Thorac Surg 2016;101:1644–45 doi:10.1016/j.athoracsur.2015.11.024 pmid:27106412

    CrossRefPubMed
36. 36.↵
    1. Rothman KJ

    . No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43–46 doi:10.1097/00001648-199001000-00010 pmid:2081237

    CrossRefPubMed